146 related articles for article (PubMed ID: 30864836)
1. The 21-gene recurrence score and effects of adjuvant radiotherapy after breast conserving surgery in early-stage breast cancer.
Dong Y; Zhang WW; Wang J; Sun JY; He ZY; Wu SG
Future Oncol; 2019 May; 15(14):1629-1639. PubMed ID: 30864836
[No Abstract] [Full Text] [Related]
2. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.
Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC
Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915
[TBL] [Abstract][Full Text] [Related]
3. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
4. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
[TBL] [Abstract][Full Text] [Related]
5. Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases.
Chen WR; Deng JP; Wang J; Sun JY; He ZY; Wu SG
Cancer Res Treat; 2019 Oct; 51(4):1437-1448. PubMed ID: 30913871
[TBL] [Abstract][Full Text] [Related]
6. Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study.
Liu KH; Zhang L; Chen JX; Lian CL; Wang J; He ZY; Wu SG
Breast; 2020 Feb; 49():233-241. PubMed ID: 31918322
[TBL] [Abstract][Full Text] [Related]
7. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Turashvili G; Chou JF; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
Breast Cancer Res Treat; 2017 Nov; 166(1):69-76. PubMed ID: 28702894
[TBL] [Abstract][Full Text] [Related]
8. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
9. 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer.
Chen XH; Zhang WW; Wang J; Sun JY; Li FY; He ZY; Wu SG
Biomark Med; 2019 Feb; 13(2):83-93. PubMed ID: 30565472
[TBL] [Abstract][Full Text] [Related]
10. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02).
Kim K; Jung SY; Shin KH; Kim JH; Han W; Lee HB; Huh SJ; Choi DH; Park W; Ahn SD; Kim SS; Kim JH; Suh CO; Kim YB; Kim IA; Kim S; Kim YJ
Breast Cancer Res Treat; 2017 Feb; 162(1):77-83. PubMed ID: 28083820
[TBL] [Abstract][Full Text] [Related]
11. Omitting Adjuvant Radiotherapy for Hormone Receptor‒Positive Early-Stage Breast Cancer in Old Age: A Propensity Score Matched SEER Analysis.
Kim YJ; Shin KH; Kim K
Cancer Res Treat; 2019 Jan; 51(1):326-336. PubMed ID: 29747486
[TBL] [Abstract][Full Text] [Related]
12. Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay.
Gage MM; Mylander WC; Rosman M; Fujii T; Le Du F; Raghavendra A; Sinha AK; Espinosa Fernandez JR; James A; Ueno NT; Tafra L; Jackson RS
Ann Oncol; 2018 May; 29(5):1280-1285. PubMed ID: 29788166
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
[TBL] [Abstract][Full Text] [Related]
14. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
[No Abstract] [Full Text] [Related]
15. The Prognostic Significance of the Oncotype DX Recurrence Score in T
Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients.
Borm KJ; Schönknecht C; Nestler A; Oechsner M; Waschulzik B; Combs SE; Münch S; Niemeyer M; Duma MN
BMC Cancer; 2019 Sep; 19(1):907. PubMed ID: 31510973
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
Daugherty EC; Daugherty MR; Bogart JA; Shapiro A
Clin Breast Cancer; 2016 Dec; 16(6):500-506.e2. PubMed ID: 27431462
[TBL] [Abstract][Full Text] [Related]
19. 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Mamounas EP; Tang G; Paik S; Baehner FL; Liu Q; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Lawrence Wickerham D; Costantino JP; Wolmark N
Breast Cancer Res Treat; 2018 Feb; 168(1):69-77. PubMed ID: 29128898
[TBL] [Abstract][Full Text] [Related]
20. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
